| Year |
Citation |
Score |
| 2024 |
Del Pino M, Vorsters A, Joura EA, Doorbar J, Haniszewski M, Gudina IA, Kodjamanova P, Velicer C, Drury R. Risk factors for human papillomavirus infection and disease: A targeted literature summary. Journal of Medical Virology. 96: e29420. PMID 38377121 DOI: 10.1002/jmv.29420 |
0.398 |
|
| 2023 |
Giuliano AR, Palefsky JM, Goldstone SE, Dubin B, Saah A, Luxembourg A, Velicer C, Tota JE. High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men. The Journal of Infectious Diseases. PMID 38012959 DOI: 10.1093/infdis/jiad485 |
0.371 |
|
| 2023 |
Wang J, Herweijer E, Nordqvist Kleppe S, Hartwig S, Velicer C, Koro C, Sundström K. High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012-2019. Preventive Medicine Reports. 35: 102342. PMID 37584061 DOI: 10.1016/j.pmedr.2023.102342 |
0.395 |
|
| 2022 |
Seeger JD, Amend KL, Turnbull BR, Zhou L, Marks MA, Velicer C, Saddier P. Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States. Vaccine. PMID 36424257 DOI: 10.1016/j.vaccine.2022.10.050 |
0.358 |
|
| 2022 |
Hansen J, Yee A, Lewis N, Li S, Velicer C, Saddier P, Klein NP. Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use. Vaccine. PMID 36396513 DOI: 10.1016/j.vaccine.2022.11.009 |
0.405 |
|
| 2022 |
Amend KL, Turnbull B, Zhou L, Marks MA, Velicer C, Saddier P, Seeger JD. Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study. Human Vaccines & Immunotherapeutics. 2073750. PMID 35714277 DOI: 10.1080/21645515.2022.2073750 |
0.338 |
|
| 2022 |
Velicer C, Luxembourg A, Chen YT, Kohn M, Saah A. Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection. Vaccine. 40: 3275-3277. PMID 35527059 DOI: 10.1016/j.vaccine.2022.04.088 |
0.367 |
|
| 2022 |
Brown DR, Castellsagué X, Ferris D, Garland SM, Huh W, Steben M, Wheeler CM, Saah A, Luxembourg A, Li S, Velicer C. Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women. Tumour Virus Research. 200236. PMID 35525430 DOI: 10.1016/j.tvr.2022.200236 |
0.338 |
|
| 2022 |
Daniels V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, Saah A, Luxembourg A, Velicer C, Chen YT, Elbasha E. Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom. Vaccine. PMID 35232593 DOI: 10.1016/j.vaccine.2022.02.067 |
0.341 |
|
| 2021 |
Wang W, Kothari S, Baay M, Garland SM, Giuliano AR, Nygård M, Velicer C, Tota J, Sinha A, Skufca J, Verstraeten T, Sundström K. Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources. Expert Review of Vaccines. PMID 34845951 DOI: 10.1080/14760584.2022.2008243 |
0.355 |
|
| 2021 |
Amend KL, Turnbull B, Zhou L, Marks MA, Velicer C, Saddier P, Seeger JD. Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016. Vaccine. PMID 34794821 DOI: 10.1016/j.vaccine.2021.10.070 |
0.383 |
|
| 2021 |
Giuliano A, Wilkin T, Bautista OM, Cheon K, Connor L, Dubey S, Luxembourg A, Rawat S, Shaw A, Velicer C, Vendetti N, Tu Y. Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men. Contemporary Clinical Trials. 106592. PMID 34678491 DOI: 10.1016/j.cct.2021.106592 |
0.44 |
|
| 2021 |
Tota JE, Giuliano AR, Goldstone SE, Dubin B, Saah A, Luxembourg A, Velicer C, Palefsky JM. Anogenital HPV Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34265048 DOI: 10.1093/cid/ciab603 |
0.431 |
|
| 2020 |
Ferris DG, Brown D, Giuliano AR, Myers E, Joura EA, Garland SM, Kjaer SK, Perez G, Saah A, Luxembourg A, Velicer C. Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial. Papillomavirus Research (Amsterdam, Netherlands). 100202. PMID 32464334 DOI: 10.1016/J.Pvr.2020.100202 |
0.462 |
|
| 2018 |
Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, ... ... Velicer C, et al. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age. Obstetrics and Gynecology. PMID 29995724 DOI: 10.1097/Aog.0000000000002736 |
0.402 |
|
| 2018 |
Meyers E, Luxembourg A, Saah A, Velicer C. Association between pap abnormalities and HPV infection in participants in HPV vaccine clinical trials. Journal of Clinical Oncology. 36: 5530-5530. DOI: 10.1200/Jco.2018.36.15_Suppl.5530 |
0.49 |
|
| 2016 |
Castellsagué X, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris DG, Joura EA, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Monsonego J, ... ... Velicer C, et al. Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region. Papillomavirus Research (Amsterdam, Netherlands). 2: 61-69. PMID 29074187 DOI: 10.1016/J.Pvr.2016.03.002 |
0.489 |
|
| 2016 |
Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiNubile MJ, Lindsay BR, Kuter BJ, Perez G, Dominiak-Felden G, Saah AJ, Drury R, Das R, Velicer C. Impact and Effectiveness Of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of Ten Years of Real-World Experience. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27230391 DOI: 10.1093/Cid/Ciw354 |
0.495 |
|
| 2015 |
Pitisuttithum P, Velicer C, Luxembourg A. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV. Expert Review of Vaccines. 14: 1405-1419. PMID 26366475 DOI: 10.1586/14760584.2015.1089174 |
0.525 |
|
| 2015 |
Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, Sings HL, Perez G, Haupt RM, Saah AJ, Lievano F, Velicer C, Drury R, Kuter BJ. An Overview of Quadrivalent Human Papillomavirus Vaccine Safety - 2006 to 2015. The Pediatric Infectious Disease Journal. PMID 26107345 DOI: 10.1097/Inf.0000000000000793 |
0.505 |
|
| 2014 |
Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, ... ... Velicer C, et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1997-2008. PMID 25274978 DOI: 10.1158/1055-9965.Epi-14-0410 |
0.502 |
|
| 2014 |
Zhang SK, Ci PW, Velicer C, Kang LN, Liu B, Cui JF, Chen F, Zhang X, Chang IJ, Roberts CC, Smith JS, Chen W, Qiao YL. Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening. Cancer Epidemiology. 38: 168-73. PMID 24522235 DOI: 10.1016/J.Canep.2014.01.004 |
0.413 |
|
| 2013 |
Zhang R, Velicer C, Chen W, Liaw KL, Wu EQ, Liu B, Cui JF, Belinson JL, Zhang X, Shen GH, Chen F, Qiao YL. Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades 1 or worse among 4215 Chinese women in a population-based study. Cancer Epidemiology. 37: 939-45. PMID 24210584 DOI: 10.1016/J.Canep.2013.10.005 |
0.459 |
|
| 2013 |
Wu EQ, Liu B, Cui JF, Chen W, Wang JB, Lu L, Niyazi M, Zhao C, Ren SD, Li CQ, Gong XZ, Smith JS, Belinson JL, Liaw KL, Velicer C, et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes & Control : Ccc. 24: 795-803. PMID 23397310 DOI: 10.1007/S10552-013-0162-8 |
0.48 |
|
| 2012 |
Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J, Lewis N, Deosaransingh K, Sy L, Ackerson B, Cheetham TC, Liaw KL, Takhar H, Jacobsen SJ. Safety of quadrivalent human papillomavirus vaccine administered routinely to females Archives of Pediatrics and Adolescent Medicine. 166: 1140-1148. PMID 23027469 DOI: 10.1001/Archpediatrics.2012.1451 |
0.472 |
|
| 2012 |
Jacobsen SJ, Sy LS, Ackerson BK, Chao CR, Slezak JM, Cheetham TC, Takhar HS, Velicer CM, Hansen J, Klein NP. An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine. 30: 4585-7. PMID 22580356 DOI: 10.1016/J.Vaccine.2012.04.103 |
0.404 |
|
| 2012 |
Chao C, Klein NP, Velicer CM, Sy LS, Slezak JM, Takhar H, Ackerson B, Cheetham TC, Hansen J, Deosaransingh K, Emery M, Liaw KL, Jacobsen SJ. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. Journal of Internal Medicine. 271: 193-203. PMID 21973261 DOI: 10.1111/J.1365-2796.2011.02467.X |
0.466 |
|
| 2010 |
Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology. 171: 357-67. PMID 20047978 DOI: 10.1093/Aje/Kwp365 |
0.515 |
|
| 2009 |
Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clinic Proceedings. 84: 864-70. PMID 19797775 DOI: 10.1016/S0025-6196(11)60503-X |
0.381 |
|
| 2009 |
Velicer C, Zhu X, Vuocolo S, Liaw K, Saah A. Prevalence and Incidence of Hpv Genital Infection in Women Sexually Transmitted Diseases. 36: 696-703. PMID 19652630 DOI: 10.1097/Olq.0B013E3181Ad25Ff |
0.5 |
|
| 2009 |
Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors Gut. 58: 661-667. PMID 18523027 DOI: 10.1136/Gut.2007.144220 |
0.329 |
|
| 2009 |
Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clinic Proceedings. 84: 864-870. DOI: 10.4065/84.10.864 |
0.466 |
|
| 2008 |
Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 665-73. PMID 18235127 DOI: 10.1200/Jco.2007.13.5905 |
0.33 |
|
| 2008 |
Ready A, Velicer CM, McTiernan A, White E. NSAID use and breast cancer risk in the VITAL cohort. Breast Cancer Research and Treatment. 109: 533-43. PMID 17674199 DOI: 10.1007/S10549-007-9665-X |
0.361 |
|
| 2006 |
Velicer CM, Kristal A, White E. Alcohol use and the risk of prostate cancer: results from the VITAL cohort study. Nutrition and Cancer. 56: 50-6. PMID 17176217 DOI: 10.1207/S15327914Nc5601_7 |
0.307 |
|
| 2006 |
Velicer CM, Dublin S, White E. Cimetidine use and the risk for prostate cancer: results from the VITAL cohort study. Annals of Epidemiology. 16: 895-900. PMID 16843010 DOI: 10.1016/J.Annepidem.2006.03.003 |
0.332 |
|
| 2006 |
Velicer CM, Heckbert SR, Rutter C, Lampe JW, Malone K. Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States) Cancer Causes and Control. 17: 307-313. PMID 16489538 DOI: 10.1007/S10552-005-0445-9 |
0.35 |
|
| 2004 |
Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. Jama. 291: 827-35. PMID 14970061 DOI: 10.1001/Jama.291.7.827 |
0.365 |
|
| 2004 |
Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH, Chung MA. Antibiotic use in relation to the risk of breast cancer Women's Oncology Review. 4: 151-152. DOI: 10.1080/1473340410001732361 |
0.362 |
|
| 2003 |
Velicer CM, Lampe JW, Heckbert SR, Potter JD, Taplin SH. Hypothesis: Is antibiotic use associated with breast cancer? Cancer Causes and Control. 14: 739-747. PMID 14674738 DOI: 10.1023/A:1026323424792 |
0.382 |
|
| 2000 |
Velicer CM, Taplin S. BRCA genetic testing: where are physicians in the decision process? Genetics in Medicine. 2: 99-99. DOI: 10.1097/00125817-200001000-00174 |
0.322 |
|
| Show low-probability matches. |